Over the last 7 days, the Biotech industry has remained flat, although notably Gilead Sciences gained 10.0%. As for the the longer term, the industry is up 9.9% over the past 12 months. As for the next few years, earnings are expected to grow by 25% per annum.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 24 Jun 2024 | US$1.2t | US$164.4b | -US$27,942,490,934.12 | 28.1x | -41.4x | 7x |
Wed, 22 May 2024 | US$1.1t | US$164.6b | -US$26,765,333,205.64 | 24.5x | -42.8x | 7x |
Fri, 19 Apr 2024 | US$1.1t | US$164.2b | -US$23,337,120,518.73 | 20.4x | -45.9x | 6.5x |
Sun, 17 Mar 2024 | US$1.2t | US$167.4b | -US$22,071,849,383.64 | 13.9x | -53.2x | 7x |
Tue, 13 Feb 2024 | US$1.2t | US$169.3b | -US$26,222,327,301.15 | 20.4x | -44.5x | 6.9x |
Thu, 11 Jan 2024 | US$1.4t | US$204.8b | -US$22,494,732,823.00 | 19.3x | -64.2x | 7.1x |
Sat, 09 Dec 2023 | US$1.3t | US$204.6b | -US$22,091,414,218.00 | 18.7x | -58.4x | 6.3x |
Mon, 06 Nov 2023 | US$1.2t | US$206.7b | -US$20,529,146,956.00 | 18.8x | -60.5x | 6x |
Wed, 04 Oct 2023 | US$1.2t | US$207.3b | -US$13,085,561,707.00 | 16.6x | -94.9x | 6x |
Fri, 01 Sep 2023 | US$1.3t | US$207.6b | -US$12,418,173,316.00 | 17.4x | -103.3x | 6.2x |
Sun, 30 Jul 2023 | US$1.1t | US$186.0b | -US$15,177,418,533.00 | 14.7x | -74.9x | 6.1x |
Tue, 27 Jun 2023 | US$1.1t | US$186.2b | -US$16,151,917,994.00 | 13.4x | -69.8x | 6.1x |
Thu, 25 May 2023 | US$1.1t | US$185.9b | -US$15,950,003,280.00 | 11.5x | -71.8x | 6.2x |
Sat, 22 Apr 2023 | US$1.2t | US$198.4b | -US$3,214,788,122.00 | 13.9x | -370.1x | 6x |
Mon, 20 Mar 2023 | US$1.1t | US$199.2b | -US$3,870,392,033.00 | 13.2x | -288.7x | 5.6x |
Wed, 15 Feb 2023 | US$1.2t | US$202.8b | -US$166,103,827.00 | 16.3x | -6973.2x | 5.7x |
Fri, 13 Jan 2023 | US$1.2t | US$203.7b | US$1.8b | 14.5x | 658.8x | 5.8x |
Sun, 11 Dec 2022 | US$1.1t | US$202.7b | US$1.4b | 14.6x | 811.7x | 5.6x |
Tue, 08 Nov 2022 | US$1.1t | US$204.5b | US$3.9b | 14.4x | 280.2x | 5.3x |
Thu, 06 Oct 2022 | US$1.1t | US$206.3b | US$5.5b | 15.3x | 193.7x | 5.2x |
Sat, 03 Sep 2022 | US$1.0t | US$206.4b | US$6.2b | 14.6x | 168.2x | 5x |
Mon, 01 Aug 2022 | US$1.1t | US$212.0b | US$11.3b | 15.6x | 93.2x | 5x |
Wed, 29 Jun 2022 | US$1.0t | US$212.3b | US$11.0b | 15.6x | 94.1x | 4.9x |
Fri, 27 May 2022 | US$1.0t | US$212.6b | US$11.1b | 15.4x | 90.6x | 4.7x |
Sun, 24 Apr 2022 | US$1.2t | US$226.6b | US$14.7b | 17.8x | 81.5x | 5.3x |
Tue, 22 Mar 2022 | US$1.3t | US$221.9b | US$10.6b | 19.5x | 120.4x | 5.8x |
Thu, 17 Feb 2022 | US$1.3t | US$216.3b | US$5.9b | 22.3x | 213x | 5.8x |
Sat, 15 Jan 2022 | US$1.3t | US$212.1b | US$2.7b | 24.4x | 482.6x | 6.2x |
Mon, 13 Dec 2021 | US$1.4t | US$212.0b | US$3.2b | 25x | 442.4x | 6.6x |
Wed, 10 Nov 2021 | US$1.5t | US$204.7b | US$843.8m | 26.3x | 1759.5x | 7.3x |
Fri, 08 Oct 2021 | US$1.5t | US$196.3b | -US$2,599,455,696.00 | 23.7x | -564.3x | 7.5x |
Sun, 05 Sep 2021 | US$1.6t | US$197.0b | -US$1,737,879,785.58 | 22.4x | -927.5x | 8.2x |
Tue, 03 Aug 2021 | US$1.5t | US$197.0b | -US$1,424,156,187.58 | 24.2x | -1083.7x | 7.8x |
-1810.8x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.11% | |
Healthcare | 0.42% | |
Biotech | 0.062% | |
Biotech | 0.062% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
GILD Gilead Sciences | US$70.67 | 10.0% +US$8.0b | -7.7% | PE181.5x | |
SRPT Sarepta Therapeutics | US$160.72 | 37.6% +US$4.1b | 48.4% | PE899.1x | |
ABBV AbbVie | US$170.39 | 1.1% +US$3.2b | 25.4% | PE50.6x | |
AMGN Amgen | US$308.16 | 1.6% +US$2.6b | 37.1% | PE43.9x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x |